Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma
Ji‐Jin Yao(Sun Yat-sen University), Ying Sun(Key Laboratory of Guangdong Province), Guan‐Qun Zhou(Sun Yat-sen University), Wangjian Zhang(Sun Yat-sen University), Wayne R. Lawrence(Albany State University), Lulu Zhang(Unknown), Siyang Wang(L-3 Communications (United States)), Fan Zhang(Sichuan University), Yinglin Peng(Sun Yat-sen University), Tian-Sheng Gao(Wuzhou Red Cross Hospital)
Cited by 30
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3
|Cancer Research|2019|423
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
|Journal of Clinical Oncology|2021|393
Microneedle-mediated transdermal drug delivery for treating diverse skin diseases
|Acta Biomaterialia|2020|247